Drying polymeric drug-loaded nanocapsules: The wet granulation process as a promising approach

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 1, 2010, Pages 616-621

  Friedrich, R B ^a   Fontana, M C ^a   Bastos, M O ^a   Pohlmann, A R ^b   Guterres, S S ^b   Beck, R C R ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dexamethasone; Drying; Granules; Nanocapsules; Nanoparticles; Stability; Wet granulation

Indexed keywords

ALTERNATIVE METHODS; DEXAMETHASONE; DEXAMETHASONES; DRUG CONTENT; DRUG MODEL; FLOW PROPERTIES; GRANULES; INDUSTRIAL DEVELOPMENT; MEAN PARTICLE SIZE; MOISTURE CONTENTS; MORPHOLOGICAL ANALYSIS; MORPHOLOGICAL CHARACTERISTIC; NANOCARRIERS; PHYSICO-CHEMICAL STABILITY; POLYMERIC NANOPARTICLES; REDISPERSIONS; ROOM TEMPERATURE; SEM; WET GRANULATION;

DRYING; GRANULATION; NANOCAPSULES; NANOPARTICLES; POLYMERS; STABILITY; WATER CONTENT;

PARTICLES (PARTICULATE MATTER);

DEXAMETHASONE; NANOCAPSULE; POLYMER;

ANALYSIS OF VARIANCE; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; METHODOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSPENSION; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; MICROSCOPY, ELECTRON, SCANNING; NANOCAPSULES; PARTICLE SIZE; POLYMERS; SUSPENSIONS;

EID: 77951889286     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.1732     Document Type: Article

References (39)

1. P. D. Marcatto and N. Durán, J. Nanosci. Nanotechnol. 8, 2216 (2008).
2. S. R. Schaffazick, A. R. Pohlmann, L. L. Freitas, and S. S. Guterres, Acta Farm. Bonaerense 21, 99 (2002).
3. M. J. Alonso, Biomed. Pharmacolher. 58, 168 (2004).
4. L. Cruz, S. R. Schaffazick, T. D. Costa, L. U. Soares, G. Mezzalira, N. P. da Silveira, A. R. Pohlmann, and S. S. Guterres, J. Nanosci. Nanotechnol. 6, 3154 (2006).
5. D. Kim and D. C. Martin, Biomaterials 27, 3031 (2006).
6. C. P. Reis, J. R. Neufeld, A. J. Ribeiro, and F. Veiga, Nanomedicine (NBM) 2, 8 (2006).
7. A. F. Ourique, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Int. J. Pharm. 352, 1 (2008).
8. M. Saez, M. Gusmán, J. Molpeceres, and M. R. Aberturas, Eur. J. Pharm. Biopharm. 50, 379 (2000).
9. S. De Chasteigner, H. Fessi, G. Cavé, J. P. Devissaguet, and F. Puisieux, S.T.P. Pharma Sci. 5, 242 (1995).
10. S. S. Guterres, H. Fessi, G. Barratt, J. P. Devissaguet, and F. Puisieux, Int. J. Pharm. 113, 57 (1995).
11. A. R Pohlmann, V. Weiss, O. Merlins, N. P. Da Silveira, and S. S. Guterres, Eur. J. Pharm. Sci. 16, 305 (2002).
12. R. C. R. Beck, S. S. Guterres, R. J. Freddo, C. B. Michalowski, I. Barcellos, and J. A. Funck, Acta Farm. Bonaerense 22, 11 (2003).
13. S. R. Schaffazick, A. R. Pohlmann, G. Mezzalira, and S. S. Guterres, J. Braz, Chem. Soc. 17, 562 (2006).
14. R. B. Friedrich, M. C. Fontana, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Quím. Nova 31, 1131 (2008).
15. S. R. Schaffazick, A. R. Pohlmann, T. Dalla-Costa, and S. S. Guterres, Eur. J. Pharm. Biopharm. 56, 501 (2003).
16. W. Abdelwahed, G. Degobert, and H. Fessi, Int. J. Pharm. 309, 178 (2006).
17. C. R. Miiller, V. L. Bassani, A. R. Pohlmann, C. B. Michalowski, P. R. Petrovick, and S. S. Guterres, Drug Dev. Ind. Pharm. 26, 343 (2000).
18. P. Tewa-Tagne, S. Briançon, and H. Fessi, Int. J. Pharm. 325, 63 (2006).
19. S. S. Guterres, R. C. R. Beck, and A. R. Pohlmann, Braz. J. Phys. 39, 205 (2009).
20. E. M. Aulton, Delineamento de formas farmacSuticas, Artmed, Porto Alegre (2000).
21. A. GUrsoy, L. Eroglu, S. Ulutin, M. Tasyurek, H. Fessi, F. Puisieux, and J. P. Devissaguet, Int. J. Pharm. 52, 101 (1989).
22. S. S. Guterres, V. Weiss, L. L. Freitas, and A. R. Pohlmann, Drug Delivery 7, 195 (2000).
23. R. C. R. Beck, A. R. Pohlmann, and S. S. Guterres, J. Microencapsulation 21, 499 (2004).
24. R. C. R. Beck, S. E. Hass, S. S. Guterres, M. I. Ré, E. V. Benvenutti, and A. R. Pohlmann, Quim. Nova 29, 990 (2006).
25. R. C. R. Beck, A. R. Pohlmann, C. Hoffmeister, M. R. Gallas, E. Collnot, U. Schaefer, S. S. Guterres, and C. M. Lehr, Eur. J. Pharm. Biopharm. 67, 18 (2007).
26. S. S. Guterres, C. R. Müller, C. B. Michalowski, A. R. Pohlmann, and T. D. Costa, 5. T. P. Pharma Sci. 11, 229 (2001).
27. C. Schmidt and R. Bodmeier, J. Control. Release 57, 115 (1999).
28. H. Fessi, F. Puisieux, and J. P. Devissaguet, European Patent 0274961 A1, 20 (1988).
29. R. C. R. Beck, Acta Farm. Bonaerense 42, 127 (2001).
30. International Conference on Harmonization (ICH), Gudeline on Validation of Analytical Procedure Q2 (Rl): Text and Methodology (2005).
31. S. N. Chee, A. L. Johansen, L. G. J. Karlsen, and P. W. S. Heng, Chem. Pharm. Bull. 53, 770 (2005).
32. L. N. Prista, A. C. Alves, and R. Morgado, Tecnologia Farmacèutica, Fundação Calouste Gulbenkian, Lisboa (1995).
33. K. Marshall, Teoria e Prática na Indústria Farmacêutica, edited by L. Lachman, H. A. Lieberman, and J. L. Kanig, Fundação Calouste Gulbekian, Lisboa (2001), Vol. 1, pp. 113-170.
34. US Pharmacopeia XXX, US Pharmacopeia Convention, Rockville (2007).
35. P. Tewa-Tagne, G. Degobert, B. Stéphanie, C. Bordes, 3. H. Gauvrit, P. Lanteri, and H. Fessi, Pharm. Res. 24, 650 (2007).
36. R. L. Carr, Chem. Eng. 72, 163 (1965).
37. H. H. Hausner, Int. J. Powder Metall. 3, 7 (1967).
38. R. B. Shah and M. A. Tawakkul, AAPS Pharm. Sci. 9, 250 (2008).
39. P. Tewa-Tagne, S. Briancon, and H. Fessi, Eur. J. Pharm. Sci. 30, 124 (2007).